XT2
Based on 2 publication(s) in Google Scholar
XT2 is a selective NIK inhibitor with an IC50 of 9.1 nM. XT2 dose-dependently inhibits the mRNA of TNFα, CCL2, CCL5, CXCL5, and NOS2. XT2 reduces serum ALT. XT2 can be used for research on CCl4 (HY-Y0298)-induced liver injury.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 99.60%
- No. CAS: 2582816-37-1
- Fòrmula: C19H14FN5OS
- Peso molecular:379.41
-
Almacenamiento:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Actividad biológica
Descripciòn
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Sf9 | IC50 |
9.1 nM
Compound: 46; (R)-44, XT2
|
Inhibition of recombinant human N-terminal GST-tagged NIK (318 to 947 residues) expressed in baculovirus infected Sf9 cells using ultrapure ATP as substrate measured after 1 hr by ADP-glo assay
Inhibition of recombinant human N-terminal GST-tagged NIK (318 to 947 residues) expressed in baculovirus infected Sf9 cells using ultrapure ATP as substrate measured after 1 hr by ADP-glo assay
|
[PMID: 32216342] |
In Vitro
XT2 (500 nM) is a selective NIK binder with Kd = 4.9 nM and no apparent affinity for 97 other kinases at 500 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Primary hepatocytes
-
Concentration:0, 1, 10 µM
-
Incubation Time:16 h
-
Result:Suppressed NIK mediated proteolysis of p100 to p52.
Did not affect the protein levels of NIK within the cell.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (wild-type)[1]
-
Dosage:40 mg/kg (30 min before CCl4); 40 mg/kg (3, 6, and 9 h after CCl4)
-
Administration:intravenous; 30 min before CCl4 and at 3, 6, and 9 h after CCl4
-
Result:At 12 h after CCl4, serum ALT levels were lower than in the untreated vehicle group.
Liver mRNA expression of TNFα, NOS2, CCL5, CXCL5, and CCL2 was reduced compared with the untreated vehicle group.
F4/80-positive area in liver tissue was lower than in vehicle-treated mice, indicating reduced macrophage infiltration.
Parmacokinetics
Chemical Information
-
No. CAS 2582816-37-1
-
Appearance Solid
-
Peso molecular 379.41
-
Fòrmula C19H14FN5OS
-
Color Light yellow to yellow
-
SMILES
FC1=CC=C(C#C[C@@](O)(C2=NC=CS2)C)C=C1C(C3=N4)=CNC3=CN=C4N
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (2)
-
Journal Impact Factor
-
Most Recent
Solvente y solubilidad
In Vitro:
DMSO : 50 mg/mL (131.78 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
Pureza y Documentación
Referencias
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.6357 mL | 13.1784 mL | 26.3567 mL | 65.8918 mL |
| 5 mM | 0.5271 mL | 2.6357 mL | 5.2713 mL | 13.1784 mL | |
| 10 mM | 0.2636 mL | 1.3178 mL | 2.6357 mL | 6.5892 mL | |
| 15 mM | 0.1757 mL | 0.8786 mL | 1.7571 mL | 4.3928 mL | |
| 20 mM | 0.1318 mL | 0.6589 mL | 1.3178 mL | 3.2946 mL | |
| 25 mM | 0.1054 mL | 0.5271 mL | 1.0543 mL | 2.6357 mL | |
| 30 mM | 0.0879 mL | 0.4393 mL | 0.8786 mL | 2.1964 mL | |
| 40 mM | 0.0659 mL | 0.3295 mL | 0.6589 mL | 1.6473 mL | |
| 50 mM | 0.0527 mL | 0.2636 mL | 0.5271 mL | 1.3178 mL | |
| 60 mM | 0.0439 mL | 0.2196 mL | 0.4393 mL | 1.0982 mL | |
| 80 mM | 0.0329 mL | 0.1647 mL | 0.3295 mL | 0.8236 mL | |
| 100 mM | 0.0264 mL | 0.1318 mL | 0.2636 mL | 0.6589 mL |
Keywords
- XT2
- 2582816-37-1
- XT 2
- XT-2
- NF-κB
- TNF Receptor
- CXCR
- NO Synthase
- Phosphatase
- Nuclear factor-κB
- Nuclear factor-kappaB
- Tumor Necrosis Factor Receptor
- TNFR
- CXC chemokine receptors
- C-X-C motif chemokine receptors
- Nitric oxide synthases
- NOS
- NF-κB2 proteolytic processing
- NIK inhibitor
- carbon tetrachloride-induced liver injury
- hepatocytes
- immune cell infiltration
- inflammatory gene expression
- liver inflammation
- noncanonical NF-κB signaling
- p100 cleavage
- p52
- Inhibitor
- inhibitor
- inhibit